HAL vs IKT · P/E 9.3, $19.05B cap vs $215.2M cap
Halliburton Company (HAL) versus Inhibikase Therapeutics Inc (IKT) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Inhibikase Therapeutics Inc (IKT) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported IKT revenue for 2024-12-31 was $0. Net income was -$27.5M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. IKT currently screens at market cap $215.2M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. IKT currently screens at market cap $215.2M.
Not investment advice. Open the HAL and IKT stock pages for the full models.
Not investment advice.